Wide Variation Exists In Technical Execution Of Scans And Compression Forces Used During Mammography

Friday, March 6, 2015
HealthImaging (3/6, Godt) reports that “breast compression, while uncomfortable for some women, is a necessary component of mammography.” Research published in the European Journal of Radiology “has shown that, because of a lack of consistent guidelines, a wide variation exists in the technical execution of scans and the compression forces used.” The investigators “suggested standardization that measures pressure rather than force could improve patient care.” 

Ultrasound Lags Behind MRI When It Comes To Screening For Supplemental Breast Cancer

Thursday, March 5, 2015
Radiation Therapy News (3/5, Santos) reports that research “published in the American Journal of Roentgenology (AJR) found that ultrasound lags behind MRI when it comes to screening for supplemental breast cancer.” In a press release, the researchers wrote, “To realize ultrasound’s potential to increase the number of cancers detected, intensive training programs need to be put in place for physician performers and interpreters for both handheld and automated breast ultrasound systems.”

Study: Nearly Half Of Women Who Are Eligible For Mammography Screening Have Never Heard Of Breast Density

Tuesday, March 3, 2015
Aunt Minnie (3/3, Yee) reports that research published in the Journal of Clinical Oncology indicates that “nearly half of women who are eligible for mammography screening have never heard of breast density, and approximately half are unaware of breast density’s effect on cancer detection and risk.” The investigators found that “this knowledge gap appears to be influenced by factors such as race, income, and education.” 

Breast Biopsies May Be Unnecessary For Breast Lesions Found By Breast MRI And Characterized As BI-RADS 2

Wednesday, February 25, 2015
Diagnostic Imaging (2/25) reports that research published in Clinical Radiology suggests that “breast biopsies are unnecessary for breast lesions found by breast MRI and characterized as BI-RADS 2.” In the study, “no lesions that were classified as BI-RADS 2 were found to be malignant.”